Survey participants’ awareness of Canadian Task Force on Preventive Health Care guidelines*
| Guideline | Evaluation year | ||||||
|---|---|---|---|---|---|---|---|
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
| Cancer screening guidelines (% surveyed who were aware of guideline) | |||||||
| Breast cancer | 85 | 89 | 91 | 90 | 75 | – | – |
| Breast cancer — update | NR | NR | NR | NR | 47 | 84 | 90 |
| Cervical cancer | 88 | 89 | 93 | 89 | 82 | 83 | 87 |
| Prostate cancer | 77 | 81 | 83 | 88 | 81 | 84 | 82 |
| Lung cancer | NR | NR | 49 | – | – | – | – |
| Colorectal cancer | NR | NR | 84 | – | – | – | – |
| Esophageal adenocarcinoma | NR | NR | NR | NR | NR | NR | 27 |
| Mean awareness score across cancer screening guidelines, % | 79.9 | ||||||
| Lifestyle and prevention guidelines (% surveyed who were aware of guideline) | |||||||
| Obesity in children | NR | 18 | – | – | – | – | – |
| Obesity in adults | NR | 22 | – | – | – | – | – |
| Tobacco smoking in children and adolescents | NR | NR | NR | 16 | – | – | – |
| Mean awareness score across lifestyle prevention guidelines, % | 18.6 | ||||||
| Other guidelines (% surveyed who were aware of guideline) | |||||||
| Cognitive impairment | NR | NR | 24 | – | – | – | – |
| Developmental delay | NR | NR | 24 | – | – | – | – |
| Hepatitis C | NR | NR | NR | 38 | |||
| Asymptomatic bacteriuria in pregnancy | NR | NR | NR | NR | 33 | 48 | – |
| Asymptomatic thyroid dysfunction | NR | NR | NR | NR | NR | 62 | 44 |
| Impaired vision | NR | NR | NR | NR | 17 | – | – |
| Mean awareness score across other task force guidelines, % | 36.2 | ||||||
Note: NR = guideline not released, task force = Canadian Task Force on Preventive Health Care.
↵* “–” indicates guideline was not evaluated that year.